Skip to content
Peptigraph home

Is enclomiphene a SERM?

Yes: a clinical evidence review groups enclomiphene citrate with clomiphene as a selective estrogen receptor modulator used for low testosterone in men.

SERM (not a peptide)Updated

Short answer

Yes: a clinical evidence review groups enclomiphene citrate with clomiphene as a selective estrogen receptor modulator used for low testosterone in men.[1]

What the SERM trials found

A meta-analysis of randomised trials of clomiphene and enclomiphene found SERM therapy raised total testosterone, with no significant difference from testosterone gel.[2]

In men with obesity-related androgen deficiency, pooled enclomiphene studies showed a testosterone rise of 7.50 nmol/L.[3]

A drug profile describes its action as an antagonist at the estrogen receptor that drives gonadotropin-dependent testosterone secretion.[4]

More on Enclomiphene

Sources

  1. 1Are SERMs safe and effective for the treatment of hypogonadism in men?The Journal of family practice · 2022PMID 35259334Accessed 2 Oct 2026
  2. 2Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials.Archives of endocrinology and metabolism · 2025PMID 41066380Accessed 2 Oct 2026
  3. 3Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis.Andrology · 2023PMID 36604313Accessed 2 Oct 2026
  4. 4Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men.IDrugs : the investigational drugs journal · 2009PMID 19204885Accessed 11 Oct 2026

Found an error? Report a correction.